220 related articles for article (PubMed ID: 1604245)
1. Western blot analysis of human IgG reactive with the collagenous portion of C1q: evidence of distinct binding specificities.
Mårtensson U; Sjöholm AG; Sturfelt G; Truedsson L; Laurell AB
Scand J Immunol; 1992 Jun; 35(6):735-44. PubMed ID: 1604245
[TBL] [Abstract][Full Text] [Related]
2. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.
Wisnieski JJ; Jones SM
J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123
[TBL] [Abstract][Full Text] [Related]
3. Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome.
Wisnieski JJ; Naff GB
Arthritis Rheum; 1989 Sep; 32(9):1119-27. PubMed ID: 2528353
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Anti-C1q Autoantibodies by Western Blot.
Verlemyr A; Truedsson L; Skattum L
Methods Mol Biol; 2019; 1901():183-189. PubMed ID: 30539577
[TBL] [Abstract][Full Text] [Related]
5. IgG autoantibody to the collagen-like region of Clq in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases.
Wisnieski JJ; Jones SM
J Rheumatol; 1992 Jun; 19(6):884-8. PubMed ID: 1404125
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
Antes U; Heinz HP; Loos M
Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in systemic lupus erythematosus and urticarial vasculitis.
D'Cruz DP; Wisnieski JJ; Asherson RA; Khamashta MA; Hughes GR
J Rheumatol; 1995 Sep; 22(9):1669-73. PubMed ID: 8523343
[TBL] [Abstract][Full Text] [Related]
8. Human autoantibodies against Clq: lack of cross reactivity with the collectins mannan-binding protein, lung surfactant protein A and bovine conglutinin.
Mårtensson U; Thiel S; Jensenius JC; Sjöholm AG
Scand J Immunol; 1996 Mar; 43(3):314-20. PubMed ID: 8602466
[TBL] [Abstract][Full Text] [Related]
9. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.
Uwatoko S; Mannik M
J Clin Invest; 1988 Sep; 82(3):816-24. PubMed ID: 3262124
[TBL] [Abstract][Full Text] [Related]
10. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
Marder RJ; Potempa LA; Jones JV; Toriumi D; Schmid FR; Gewurz H
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():25-34. PubMed ID: 6375256
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis.
Cook AD; Rowley MJ; Wines BD; Mackay IR
J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456
[TBL] [Abstract][Full Text] [Related]
12. C1q solid-phase radioimmunoassay: evidence for detection of antibody directed against the collagen-like region of C1q in sera from patients with systemic lupus erythematosus.
Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
Clin Exp Immunol; 1987 Jul; 69(1):98-106. PubMed ID: 3498589
[TBL] [Abstract][Full Text] [Related]
13. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
Antes U; Heinz HP; Loos M
J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
[TBL] [Abstract][Full Text] [Related]
14. [Autoantibodies against the complement component C1q in systemic lupus erythematosus].
Antes U; Heinz HP; Hartung K; Loos M
Klin Wochenschr; 1990 Nov; 68(21):1066-70. PubMed ID: 2084321
[TBL] [Abstract][Full Text] [Related]
15. IgG and IgA antibodies to the collagen-like region of C1q in rheumatoid vasculitis.
Siegert CE; Daha MR; van der Voort EA; Breedveld FC
Arthritis Rheum; 1990 Nov; 33(11):1646-54. PubMed ID: 2146965
[TBL] [Abstract][Full Text] [Related]
16. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus.
Siegert C; Daha M; Westedt ML; van der Voort E; Breedveld F
J Rheumatol; 1991 Feb; 18(2):230-4. PubMed ID: 2023216
[TBL] [Abstract][Full Text] [Related]
17. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
Kohro-Kawata J; Wener MH; Mannik M
J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
[TBL] [Abstract][Full Text] [Related]
18. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE
Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
[TBL] [Abstract][Full Text] [Related]
19. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
[TBL] [Abstract][Full Text] [Related]
20. C1q solid-phase radioimmunoassay: binding properties of solid-phase C1q and evidence that C1q-binding IgG complexes in systemic lupus erythematosus are not bound to endogenous C1q.
Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
J Immunol Methods; 1984 Oct; 73(1):67-74. PubMed ID: 6436382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
